Skopos Labs, Inc. Kymera Therapeutics, Inc. Call Options Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KYMR
# of Institutions
228Shares Held
73.2MCall Options Held
178KPut Options Held
64.6K-
Baker Bros. Advisors LP New York, NY6.65MShares$423 Million2.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.35MShares$404 Million4.91% of portfolio
-
Bvf Inc San Francisco, CA5.5MShares$350 Million9.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.42MShares$345 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA5.2MShares$331 Million0.05% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $3.48B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...